The BioScience business unit provides products and services to support life science researchers in both industry and academia. It consists of two business fields: Life Science and Discovery & Development Solutions.
BioScience reported sales of € 421 million in 2011. Growth was driven by a broad portfolio of products and services. Geographically, sales gains were primarily driven by Asian and Latin American markets. BioScience sales were fueled by strong growth in strategic market segments such as multiplexing and flow cytometry and hampered by a slowdown in academic and government funding. New BioScience product innovations, such as the Scepter™ handheld automated cell counter and the Samplicity™ filter system, continued to win industry accolades in 2011 and establish Merck Millipore as a life science leader.
In 2011, with the acquisition of Seattle-based Amnis Corporation, the BioScience business unit gained access to leading technology in high-speed cell imaging instrumentation used in flow cytometry applications. This acquisition, which complements the business unit’s Guava product range, puts Merck Millipore at the forefront of cell analysis and helps the division address several unmet customer needs.
back
